Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Cugene Inc.

HQ: Waltham, MA source · cugene.com ↗

Clinical Phase 1

Keywords: oncology immunology cancer autoimmune diseases Systemic Lupus Erythematosus SLE (Systemic Lupus) CUG252

Location: Waltham, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

Apr 24, 2023 Trial start Phase 1: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus source ↗
Nov 9, 2021 Trial start I: A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers source ↗

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT05866861	A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus	Phase 1	Completed	Apr 24, 2023	Apr 1, 2025 (actual)
NCT05328557	A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers	I	Completed	Nov 9, 2021	Aug 3, 2022 (actual)